{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:34:43Z","timestamp":1793320483843,"version":"4.5.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Multiple daily injections therapy in older adults with diabetes can negatively impact glycemic control and comorbidities. This issue may be overcome with advanced diabetes technology that reduces hypoglycemia and hyperglycemia. The present study evaluated real-world glycemic outcomes of a United States (US) cohort \u226565 years using the MiniMed\u2122 780G (MM780G) advanced hybrid closed-loop system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>CareLink\u2122 personal data as of December 18, 2024, for U.S. MM780G system users \u226565 years, were de-identified and analyzed. Metrics, including time in range (TIR 70\u2013180 mg\/dL), time in tight range (TITR 70\u2013140 mg\/dL), time below range 70 mg\/dL (TBR70), and time above range 180 mg\/dL and 250 mg\/dL (TAR180 and TAR250, respectively), with and without recommended optimal settings (ROS, 100 mg\/dL glucose target with 2 h active insulin time) were determined. Subanalyses based on age group (\u226575 years) and type 1 diabetes (T1D) or type 2 diabetes (T2D) were, also, conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The overall cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 8542) had a mean TIR, TITR, TBR70, TAR180, and TAR250 of 78.4%, 51.4%, 0.9%, 20.7%, and 3.6%, respectively, with a 6.8% glucose management indicator. For ROS users (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2753), TIR and TITR were higher (81.9% and 55.9%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and TAR180 and TAR250 were lower (17.2% and 2.5%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Data trended similarly among the population aged \u226575 years, and no differences were observed between T1D and T2D.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In a real-world setting, a U.S. cohort aged \u226565 years using the MM780G system achieved consensus-recommended glycemic targets. Use of ROS enabled more users to achieve an even higher level of glycemic control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15209156251376654","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:09:32Z","timestamp":1758010172000},"page":"989-996","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Effectiveness of the MiniMed\u2122 780G Advanced Hybrid Closed-Loop System for People \u226565 Years with Type 1 or Type 2 Diabetes in the United States"],"prefix":"10.1177","volume":"27","author":[{"given":"Albert","family":"Chien","sequence":"first","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Shin","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Liu","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcelia","family":"Arrieta","sequence":"additional","affiliation":[{"name":"Medtronic Bakken Research Center, Maastricht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-4194","authenticated-orcid":false,"given":"Toni L.","family":"Cordero","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrine R.","family":"Swensen","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-3385","authenticated-orcid":false,"given":"Robert A.","family":"Vigersky","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. Available from: https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html [Last accessed: November22 2024]."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.36469\/001c.124604"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0196"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0268"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0114"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2014.0330"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1018-0"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1065-6"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S007"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1624"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12817"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-er01b"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-1058"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0446"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14714"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0433"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0470"},{"key":"e_1_3_3_20_2","first-page":"193229682513183","article-title":"Performance of an automated insulin delivery system in people living with type 2 diabetes and insulin resistance: First real-world evidence in 26 427 users","author":"Thijs I","year":"2025","unstructured":"Thijs I, , Arrieta A, , Casta\u00f1eda J, et al. Performance of an automated insulin delivery system in people living with type 2 diabetes and insulin resistance: First real-world evidence in 26 427 users. J Diabetes Sci Technol, 2025:19322968251318373.","journal-title":"J Diabetes Sci Technol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0206"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16227"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078432"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0393"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818822496"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108289"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab688"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0486"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0404"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0310"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0442"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3842"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14807"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac022"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13421"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15196"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15351"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0586"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.2337\/cd23-0025"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02763"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16033"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15868"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15209156251376654","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156251376654","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156251376654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:19:12Z","timestamp":1777400352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15209156251376654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.1177\/15209156251376654"],"URL":"https:\/\/doi.org\/10.1177\/15209156251376654","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}